dr. mcdermott discusses the future of immune checkpoints in rcc
Published 7 years ago • 72 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
2:18
dr. mcdermott on immunotherapy-related aes in rcc
-
7:50
a look to the future in rcc
-
1:14
dr. bhatt on identification of immune checkpoint pathway in rcc
-
0:54
dr. mcdermott on immunotherapy as a standard of care in rcc
-
1:24
dr. mcdermott on the use of anti–pd-1 combinations in mrcc
-
1:22
dr. mcdermott on major findings of efficacy and safety of nivolumab in rcc
-
11:46
immune checkpoint inhibitors in renal cell carcinoma
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
4:04
a novel cxcr4 inhibitor for rcc and a novel immunotherapy endpoint | david mcdermott
-
3:59
the future of renal cell carcinoma
-
1:53
dr. mcdermott on long-term benefit with nivolumab in rcc
-
5:25
future directions for rcc research
-
11:49
the future of cancer: prevention and precision medicine
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
19:18
predictions for 2023: dr. bill morice
-
13:27
how timely talking about dying allows shaping the end of life | daisy janssen | tedxsittardgeleen
-
4:00
earlier use of checkpoint inhibitors
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer